4//SEC Filing
Kaundinya Ganesh Venkataraman 4
Accession 0001179110-18-006571
CIK 0001235010other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:08 PM ET
Size
8.7 KB
Accession
0001179110-18-006571
Insider Transaction Report
Form 4
Venkataraman Ganesh
Senior V.P., Research
Transactions
- Exercise/Conversion
Restricted Stock Units
2018-05-08−1,409→ 15,504 total→ Common Stock (1,409 underlying) - Exercise/Conversion
Common Stock
2018-05-08+1,409→ 496,709 total - Sale
Common Stock
2018-05-08$18.09/sh−493$8,918→ 496,216 total
Footnotes (4)
- [F1]Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F3]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F4]Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001294284
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:08 PM ET
- Size
- 8.7 KB